Why Is Multidisciplinary Working Essential To Modern Cancer Care?

Cancer care increasingly involves complex diagnostic processes, specialised treatment technologies and decisions that require input from several clinical disciplines.

Multidisciplinary working enables healthcare professionals to combine their expertise, evaluate relevant evidence and coordinate care across different stages of the cancer pathway.

For healthcare organisations, effective oncology collaboration is an important component of clinical governance, quality assurance and service delivery.

As oncology advances towards more personalised treatment approaches, coordinated working is also becoming increasingly relevant to the integration of diagnostic information, treatment planning and specialist expertise.

What is multidisciplinary working in oncology?

Multidisciplinary working involves professionals from different clinical and healthcare disciplines contributing to decisions about cancer diagnosis, treatment and ongoing management.

In oncology, this commonly takes place through multidisciplinary teams (MDTs), which review individual cases and consider appropriate management options.

Depending on the cancer type and clinical context, an MDT may include medical oncologists, clinical oncologists, surgeons, radiologists, pathologists, specialist nurses and other relevant professionals.

Medical physicists, radiographers, molecular pathology specialists and genetic experts may also contribute where their expertise is required.

The composition of a team depends on the clinical question being considered. Its purpose is to bring together complementary perspectives, ensuring that decisions reflect the available diagnostic evidence, relevant treatment options and the patient’s individual circumstances.

The European Society for Medical Oncology provides professional guidance and educational resources that support evidence-based, multidisciplinary approaches to cancer care.

Supporting evidence-based treatment decisions

Cancer management can involve several potential treatment approaches, including surgery, systemic anticancer therapies and radiotherapy.

Determining the most appropriate approach requires consideration of factors such as tumour type, disease stage, molecular characteristics, previous treatment and relevant clinical evidence.

Multidisciplinary discussion provides a structured opportunity to review these factors collectively. Radiological findings, histopathology reports and molecular test results can be considered alongside specialist assessments.

This is particularly important where treatment decisions involve several disciplines or where emerging diagnostic information may influence the available options. Collaboration also creates opportunities to identify questions requiring further investigation or specialist review.

Multidisciplinary working does not remove the need for individual clinical judgement. Rather, it provides a framework for informed decision-making, supported by appropriate expertise, professional accountability and established clinical guidance.

Integrating advances in precision oncology

Developments in molecular diagnostics, genomic profiling and advanced imaging are increasing the volume and complexity of information available to oncology professionals.

Precision oncology aims to use relevant biological and clinical information to inform treatment decisions. However, interpreting this information often requires collaboration between clinicians, pathologists, molecular specialists and other professionals.

For example, molecular findings may have implications for treatment selection, eligibility for targeted therapies or access to clinical trials. Their significance must be interpreted in the context of the patient’s diagnosis  and the evidence supporting a particular intervention.

Multidisciplinary collaboration can help connect these different sources of expertise. It may also support the responsible introduction of emerging technologies by ensuring they are considered alongside clinical requirements, treatments, and governance arrangements.

Coordinating radiotherapy and specialist services

Multidisciplinary working is particularly relevant to radiation oncology, where treatment planning may involve clinical oncologists, radiographers, medical physicists and other specialist professionals.

Radiotherapy delivery requires coordination across several stages, including patient assessment, imaging, treatment planning, quality assurance and treatment delivery. Each stage depends on clearly defined responsibilities and effective communication.

Their implementation requires appropriate expertise, equipment, quality assurance processes and clinical governance.

Collaboration between clinical and technical teams helps ensure that treatment decisions and delivery processes are aligned with established protocols and the requirements of individual cases.

Strengthening clinical governance and quality assurance

Multidisciplinary working also contributes to wider healthcare governance. Structured case discussions, documented decisions and agreed clinical pathways can support transparency, accountability and consistency in clinical practice.

For healthcare organisations operating across several locations, there may be opportunities to share protocols, educational resources and learning from service evaluations.

However, common frameworks must remain compatible with national regulations, local clinical requirements and the professional responsibilities of individual practitioners.

Building a collaborative oncology workforce

Successful multidisciplinary working depends on more than bringing different professionals together. It requires clear communication, mutual professional respect, appropriate training and sufficient time for meaningful clinical discussion.

Healthcare organisations can support collaboration through continuing professional development, joint educational programmes, shared learning initiatives and opportunities for professionals to understand the responsibilities of other disciplines.

Learn more about Stingray Healthcare Group and its approach to clinical collaboration and oncology innovation across Europe.